Hello™, a trailblazer in customised health and wellness based in Miami, announces with enthusiasm its successful £4 million self-funded pre-seed investment round. This pivotal financial achievement emphasises the company’s commitment to overhauling the wellness and weight loss sector with its innovative GLP-1 medication therapies and AI-led platform.

This robust financial support positions Hello™ at the forefront of redefining weight management strategies. The company’s distinctive method integrates the latest medical insights with tailored lifestyle changes, providing a custom-fit wellness path for every user.

“Our mission statement at Hello™ is to redefine what it means to achieve wellness and weight loss. The confidence shown by our investors enables us to accelerate our mission, enhancing our capabilities to deliver personalized, effective, and science-backed weight loss solutions. We’re not just creating a product; we’re creating a movement towards a healthier future for everyone.”

The investment will be deployed to enhance Hello’s unique technology, augment its team of specialists, and extend its reach to individuals in pursuit of a scientifically based, customised weight loss journey. Hello™ strives to deliver more than simple weight loss solutions; it aims for a complete lifestyle overhaul.

In its exclusive initial phase, Hello™ has validated the success of its programme, with numerous clients in the USA achieving significant, lasting weight loss. As it moves towards a public launch, the company is poised to extend its revolutionary wellness and weight loss approach to a broader demographic nationwide.